ID   GM12864
AC   CVCL_L256
DR   CLO; CLO_0022833
DR   EFO; EFO_0005337
DR   Coriell; GM12864
DR   ENCODE; ENCBS208AAA
DR   ENCODE; ENCBS315VRM
DR   ENCODE; ENCBS388ZNW
DR   ENCODE; ENCBS395VNK
DR   ENCODE; ENCBS605TTN
DR   ENCODE; ENCBS845FQR
DR   ENCODE; ENCBS892LHC
DR   GEO; GSM112562
DR   GEO; GSM112865
DR   GEO; GSM188840
DR   GEO; GSM291691
DR   GEO; GSM421075
DR   GEO; GSM421076
DR   GEO; GSM648893
DR   GEO; GSM749676
DR   GEO; GSM749754
DR   GEO; GSM749762
DR   GEO; GSM824872
DR   GEO; GSM824873
DR   GEO; GSM945238
DR   GEO; GSM945296
DR   GEO; GSM1022664
DR   IGSR; NA12864
DR   Wikidata; Q54846161
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12864_Stam_protocol.pdf
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145901.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: CTCF ChIP-seq epigenome analysis.
CC   Omics: H3K4me3 ChIP-seq epigenome analysis.
CC   Omics: CNV analysis.
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 20
//
RX   PubMed=17122850; DOI=10.1038/nature05329;
RA   Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D.,
RA   Fiegler H., Shapero M.H., Carson A.R., Chen W.-W., Cho E.K., Dallaire S.,
RA   Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D.,
RA   Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L.,
RA   Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J.,
RA   Valsesia A., Woodwark C., Yang F.-T., Zhang J.-J., Zerjal T., Zhang J.,
RA   Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P.,
RA   Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E.;
RT   "Global variation in copy number in the human genome.";
RL   Nature 444:444-454(2006).
//
RX   PubMed=19043577; DOI=10.1371/journal.pgen.1000287;
RA   Choy E., Yelensky R., Bonakdar S., Plenge R.M., Saxena R.,
RA   De Jager P.L., Shaw S.Y., Wolfish C.S., Slavik J.M., Cotsapas C.,
RA   Rivas M.A., Dermitzakis E.T., Cahir-McFarland E., Kieff E.D.,
RA   Hafler D.A., Daly M.J., Altshuler D.M.;
RT   "Genetic analysis of human traits in vitro: drug response and gene
RT   expression in lymphoblastoid cell lines.";
RL   PLoS Genet. 4:E1000287-E1000287(2008).
//
RX   PubMed=20856902; DOI=10.1371/journal.pbio.1000480;
RA   Cheung V.G., Nayak R.R., Wang I.X.-R., Elwyn S., Cousins S.M., Morley M.,
RA   Spielman R.S.;
RT   "Polymorphic cis- and trans-regulation of human gene expression.";
RL   PLoS Biol. 8:e1000480.1-e1000480.14(2010).
//
RX   PubMed=21397061; DOI=10.1016/j.ajhg.2011.02.004;
RA   Campbell C.D., Sampas N., Tsalenko A., Sudmant P.H., Kidd J.M.,
RA   Malig M., Vu T.H., Vives L., Tsang P., Bruhn L., Eichler E.E.;
RT   "Population-genetic properties of differentiated human copy-number
RT   polymorphisms.";
RL   Am. J. Hum. Genet. 88:317-332(2011).
//
RX   PubMed=24924344; DOI=10.1186/1756-0500-7-360;
RA   Hariani G.D., Lam E.J., Havener T., Kwok P.-Y., McLeod H.L.,
RA   Wagner M.J., Motsinger-Reif A.A.;
RT   "Application of next generation sequencing to CEPH cell lines to
RT   discover variants associated with FDA approved chemotherapeutics.";
RL   BMC Res. Notes 7:360.1-360.10(2014).
//